IL309630A - Regulatory nucleic acid sequences - Google Patents
Regulatory nucleic acid sequencesInfo
- Publication number
- IL309630A IL309630A IL309630A IL30963023A IL309630A IL 309630 A IL309630 A IL 309630A IL 309630 A IL309630 A IL 309630A IL 30963023 A IL30963023 A IL 30963023A IL 309630 A IL309630 A IL 309630A
- Authority
- IL
- Israel
- Prior art keywords
- nucleic acid
- acid sequences
- regulatory nucleic
- regulatory
- sequences
- Prior art date
Links
- 150000007523 nucleic acids Chemical group 0.000 title 1
- 230000001105 regulatory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
- A61K48/0058—Nucleic acids adapted for tissue specific expression, e.g. having tissue specific promoters as part of a contruct
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Virology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2108997.4A GB202108997D0 (en) | 2021-06-23 | 2021-06-23 | Regulatory nucleic acid sequences |
| GB202111317 | 2021-08-05 | ||
| PCT/GB2022/051611 WO2022269269A1 (en) | 2021-06-23 | 2022-06-23 | Regulatory nucleic acid sequences |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309630A true IL309630A (en) | 2024-02-01 |
Family
ID=82655313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309630A IL309630A (en) | 2021-06-23 | 2022-06-23 | Regulatory nucleic acid sequences |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250129381A1 (enExample) |
| EP (1) | EP4359548A1 (enExample) |
| JP (1) | JP2024524270A (enExample) |
| KR (1) | KR20240023643A (enExample) |
| AU (1) | AU2022297795A1 (enExample) |
| CA (1) | CA3221707A1 (enExample) |
| IL (1) | IL309630A (enExample) |
| WO (1) | WO2022269269A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202319008D0 (en) * | 2023-12-13 | 2024-01-24 | Ucl Business Ltd | AAV-mediated gene therapy of diseases caused by impaired function of GLDC |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US6200560B1 (en) | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
| US6221349B1 (en) | 1998-10-20 | 2001-04-24 | Avigen, Inc. | Adeno-associated vectors for expression of factor VIII by target cells |
| US8106180B2 (en) | 2003-08-07 | 2012-01-31 | Whitehead Institute For Biomedical Research | Methods and products for expression of micro RNAs |
| US20050142581A1 (en) | 2003-09-04 | 2005-06-30 | Griffey Richard H. | Microrna as ligands and target molecules |
| WO2005056761A2 (en) | 2003-12-05 | 2005-06-23 | Massachusetts Institute Of Technology | REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| KR100614827B1 (ko) | 2004-05-06 | 2006-08-25 | 재단법인서울대학교산학협력재단 | 양방향 은닉 마코프 모델을 이용한 완숙한마이크로알엔에이 위치예측방법 및 이를 구현하기 위한컴퓨터 프로그램을 기록한 저장매체 |
| AU2015208247B2 (en) * | 2014-01-21 | 2021-05-27 | Universiteit Gent | Muscle-specific nucleic acid regulatory elements and methods and use thereof |
| AU2020392243A1 (en) * | 2019-11-28 | 2022-06-16 | Regenxbio Inc. | Microdystrophin gene therapy constructs and uses thereof |
| EP4081643A1 (en) * | 2019-12-24 | 2022-11-02 | Asklepios Biopharmaceutical, Inc. | Regulatory nucleic acid sequences |
| CN116406297A (zh) * | 2020-08-05 | 2023-07-07 | 阿斯克肋匹奥生物制药公司 | 治疗心脏疾患和充血性心力衰竭以及施用aav载体的方法 |
| US20230374542A1 (en) * | 2020-10-07 | 2023-11-23 | Asklepios Biopharmaceutical, Inc. | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21) |
-
2022
- 2022-06-23 CA CA3221707A patent/CA3221707A1/en active Pending
- 2022-06-23 JP JP2023579317A patent/JP2024524270A/ja active Pending
- 2022-06-23 US US18/572,668 patent/US20250129381A1/en active Pending
- 2022-06-23 WO PCT/GB2022/051611 patent/WO2022269269A1/en not_active Ceased
- 2022-06-23 KR KR1020247002456A patent/KR20240023643A/ko active Pending
- 2022-06-23 IL IL309630A patent/IL309630A/en unknown
- 2022-06-23 AU AU2022297795A patent/AU2022297795A1/en active Pending
- 2022-06-23 EP EP22744500.4A patent/EP4359548A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3221707A1 (en) | 2022-12-29 |
| EP4359548A1 (en) | 2024-05-01 |
| KR20240023643A (ko) | 2024-02-22 |
| JP2024524270A (ja) | 2024-07-05 |
| WO2022269269A1 (en) | 2022-12-29 |
| US20250129381A1 (en) | 2025-04-24 |
| AU2022297795A1 (en) | 2024-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3987019A4 (en) | Barcode-based nucleic acid sequence assembly | |
| PL3565905T5 (pl) | Sekwencjonowanie kwasów nukleinowych z zastosowaniem odczynników powinowactwa | |
| IL264966B (en) | De novo synthesized nucleic acid libraries | |
| DK3523430T3 (da) | Manipulerede nukleinsyremålrettede nukleinsyrer | |
| EP3784799C0 (en) | METHOD FOR DETECTING NUCLEIC ACIDS | |
| EP4745278A2 (en) | Nucleic acid indexation method | |
| EP3417062A4 (en) | EXCEPTION OF RETROVIRAL NUCLEIC ACID SEQUENCES | |
| IL254000B (en) | Nucleic acid sequence assembly | |
| EP3775210C0 (en) | NUCLEIC ACID MOLECULES FOR PSEUDOURIDYLATION | |
| EP3997205A4 (en) | Rna sequencing methods | |
| IL283219A (en) | Liver-specific regulatory nucleic acid sequences | |
| IL283775A (en) | Double-stranded nucleic acid inhibitor molecules containing a triloop | |
| IL287706A (en) | Methods for detecting nucleic acid variants | |
| EP3769769A4 (en) | REDUCED TOXICITY NUCLEIC ACID | |
| EP4367245A4 (en) | SIGNAL-ACTIVABILABLE NUCLEIC ACID COMPLEXES | |
| DK3645717T3 (da) | Modulære nukleinsyreadaptere | |
| EP4367126A4 (en) | CONDITIONALLY ACTIVATED NUCLEIC ACID COMPLEXES | |
| EP4212628C0 (en) | NUCLEIC ACID SEQUENCING PROCESS | |
| EP4032551A4 (en) | NUCLEIC ACID COMPLEX | |
| DK3833786T5 (da) | Rekombinant nucleinsyrekonstrukt | |
| EP3612160A4 (en) | P-ETHOXY NUCLEIC ACIDS FOR BCL2 INHIBITION | |
| EP3908677C0 (en) | METHOD FOR DETECTING A NUCLEIC ACID SEQUENCE | |
| EP4382110A4 (en) | HAIRPIN NUCLEIC ACID COMPOSITION | |
| EP3467835C0 (en) | IMPROVED ALIGNMENT METHOD FOR NUCLEIC ACID SEQUENCES | |
| GB202005732D0 (en) | Regulatory nucleic acid sequences |